STOCK TITAN

Palisade Bio (PALI) Debt by Year

PALI NASDAQ

Palisade Bio, Inc. held $133.4M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Palisade Bio, Inc. has filed alongside them.

FY2025 annual
Long-Term Debt N/A
Cash & Equivalents $133.4M
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PALI Debt & Cash by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-QFY2410-KFY2310-KFY2210-KFY2110-KFY2010-Q
Long-Term DebtN/AN/AN/AN/A$0-100.0%$94K
Cash & Equivalents$133.4M+1258.2%$9.8M-21.0%$12.4M+0.4%$12.4M+18.0%$10.5M+1371.9%$713K

PALI Debt & Cash by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'25FilingQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$113.6M+2073.6%$125.2M+2210.7%$132.6M+1734.4%$133.4M+1258.2%$5.2M-35.0%$5.4M-52.3%$7.2M-35.9%$9.8M-21.0%$8.0M-47.5%$11.4M-30.8%$11.3M-15.2%$12.4M+0.4%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Palisade Bio, Inc. financials

Frequently Asked Questions

Palisade Bio, Inc. held $133.4M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Palisade Bio, Inc. (PALI) reported on that line in every period on record.